Carrick Therapeutics, a company focused on creating new cancer treatments, has recently started a significant study (Phase 1b/2 clinical trial) to test a combination...
A recent clinical trial investigated olaparib's effects on patients with HER2-negative, BRCA-mutated early breast cancer, focusing on fatigue. Results showed temporary tiredness and nausea...
The next phase of an important trial for metastatic triple-negative breast cancer patients is evaluating the effectiveness of trilaciclib combined with chemotherapy.
This effort, officially...
A new multi-institutional study, led by a team of researchers including Prof Carlo Palmieri, Prof Hannah Linden, and others, investigated the effectiveness and safety...